Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs
about
Dimensional assessment of behavioral changes in the cuprizone short-term exposure model for psychosisOligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor.White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia.Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of DemyelinationThe Effects of Prenatal Iron Deficiency and Risperidone Treatment on the Rat Frontal Cortex: A Proteomic Analysis.Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway.Cyclin-dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model.Locomotor activity and anxiety status, but not spatial working memory, are affected in mice after brief exposure to cuprizone.The neurobiology of transition to psychosis: clearing the cache.The Protective Effects of Areca catechu Extract on Cognition and Social Interaction Deficits in a Cuprizone-Induced Demyelination Model.Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides.N-acetylcysteine attenuates the cuprizone-induced behavioral changes and oligodendrocyte loss in male C57BL/7 mice via its anti-inflammation actions.Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelinationConfused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia
P2860
Q30355377-DB96F599-0AB3-4FBC-8ED7-61557EBA1127Q30405077-A6AA8D71-0D39-4253-958B-99E27D62CFB4Q30442608-65D28C57-5C58-4EE9-A474-BECDB03432C5Q36065482-D41BC33F-F877-4457-AAF0-2525A7C1E737Q36169035-46383DD2-ADD0-4291-ABFF-2D8F05F1A9A6Q36389801-93CE1DBD-2F9D-424D-BDF2-EAB0F170B56AQ38648807-4F90E59B-9F65-4C79-BBA8-D93B1C5CA5B1Q39314462-18ABEEFE-E3AB-4634-8982-486812E1CAA8Q41352911-E8EC7723-4741-47E0-B187-DB04BC4C3310Q41453757-BF5339BB-553C-4F36-8BCC-2B5967E9833FQ41535826-CFD33FDE-660E-45EA-AD6A-2C5C9708EB67Q42092203-242C35A8-9D7B-484C-96AE-F58CED03458EQ42280452-BBFD70A2-F365-4C61-958C-7EDCDAB21AB6Q47578437-99C450B2-3D9A-4733-8FF5-05B8174F54FFQ57157917-49CDFC8F-368A-4480-89C1-6B0C1BE38C36Q58596335-0A081279-EAEC-483A-92BE-412384123AE2
P2860
Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recovery of behavioral changes ...... effects of antipsychotic drugs
@ast
Recovery of behavioral changes ...... effects of antipsychotic drugs
@en
type
label
Recovery of behavioral changes ...... effects of antipsychotic drugs
@ast
Recovery of behavioral changes ...... effects of antipsychotic drugs
@en
prefLabel
Recovery of behavioral changes ...... effects of antipsychotic drugs
@ast
Recovery of behavioral changes ...... effects of antipsychotic drugs
@en
P2093
P2860
P356
P1476
Recovery of behavioral changes ...... effects of antipsychotic drugs
@en
P2093
Gregory M Rose
Hong-Ju Yang
Xin-Min Li
P2860
P356
10.3389/FNBEH.2011.00031
P577
2011-07-01T00:00:00Z